Manufacturing and Production

Showing 15 posts of 5874 posts found.

Novartis eye treatment for diabetics shows positive results in Phase III trial

May 4, 2021 Manufacturing and Production DME, Novartis, diabetic macular edema, macular edema, pharma, pharma news

Novartis’ Beovu treatment for diabetic macular edema (DME) – an eye condition that can cause blindness – has shown positive …

Needle-free pandemic influenza vaccine sees preclinical proof-of-concept

May 4, 2021 Manufacturing and Production, Sales and Marketing Vaccine technology

Enesi Pharma, a US biotechnology company developing novel vaccination products, announced the development of a solid-dose recombinant H7N9 pandemic influenza …

Moderna to supply up to 500 million COVID-19 vaccines to COVAX

May 4, 2021 Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …

Sheila Frame new President for the Americas at Amryt

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.

Francesco Maria Lavino appointed CEO of F2G Ltd

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …

Macrogen Europe appoints Dr Bongcho Kim as new CEO

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …

King & Spalding announce appointment of former FDA official

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …

Are we on the cusp of an AI revolution?

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …

European Commission sues AstraZeneca over COVID-19 jab supplies

April 27, 2021 Manufacturing and Production AstraZeneca, AstraZeneca vaccine, COVID-19, EU, European Commission, covid 19 news, covid-19 news, european union, pharma, pharma news

The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 …

NICE updates guidelines on atrial fibrillation based on new evidence

April 27, 2021 Manufacturing and Production NICE

NICE has updated its guideline on the diagnosis and management of atrial fibrillation (AF) based on new evidence found since …

Hilco Industrial acquires all machinery and equipment from Legacy Pharmaceutical Switzerland

April 27, 2021 Manufacturing and Production

Hilco Industrial Acquisitions, an Amsterdam based industrial asset disposition and acquisition company, has acquired all machinery and equipment from the …

Data published on novel molecules for leukaemia treatment

April 27, 2021 Manufacturing and Production oncology

STORM Therapeutics have published new data in Nature on targeting RNA modifying enzymes for the development of new anti-cancer therapeutics, …

Home breast cancer treatment offered in UK for first time

April 27, 2021 Manufacturing and Production

Phesgo, a treatment for breast cancer, will now be offered to patients at home in the UK for the very …

Adagio raises $336 million to advance COVID-19 antibody

April 20, 2021 Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news

Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …
The Gateway to Local Adoption Series

Latest content